Bio-Connect
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane
WB analysis of various sample lysates using GTX33279 K-Cadherin antibody. Dilution : 1:1000 Loading : 25microg per lane

K-Cadherin antibody

GTX33279
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetCDH6
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    K-Cadherin antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500 - 1:2000. IHC-P: 1:50 - 1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID1004
  • Target name
    CDH6
  • Target description
    cadherin 6
  • Target synonyms
    CAD6, KCAD, cadherin-6, cadherin 6, type 2, K-cadherin (fetal kidney)
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP55285
  • Protein Name
    Cadherin-6
  • Scientific Description
    This gene encodes a member of the cadherin superfamily. Cadherins are membrane glycoproteins that mediate homophilic cell-cell adhesion and play critical roles in cell differentiation and morphogenesis. The encoded protein is a type II cadherin and may play a role in kidney development as well as endometrium and placenta formation. Decreased expression of this gene may be associated with tumor growth and metastasis. [provided by RefSeq, May 2011]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma. Chiu IJ et al., 2020 Mar 31, Cancers (Basel)
    Read more